Cover Image

Pharmacokinetic/pharmacodynamic based dosing of ciprofloxacin in complicated urinary tract infections

Ciprofloxacin is often used in treatment of complicated urinary tract infections in areas with high rates of resistance to first line agents. The aim of this study was to evaluate efficacy of ciprofloxacin in standard dosing regimens in treatment of complicated urinary tract infections. Plasma conce...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ana Sabo (Author), Ana Tomas (Author), Nataa Tomi? (Author), Momir Mikov (Author), Olga Horvat (Author), Radmila Popovi? (Author), Zdenko Tomi? (Author)
Format:	Book
Published:	Bangladesh Pharmacological Society, 2015-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
by: Alicia Rodríguez-Gascón, et al.
Published: (2023)

Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis
by: Dehong Cao, et al.
Published: (2021)

Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by <em>Enterobacteriaceae</em>
by: Ga Eun Park, et al.
Published: (2021)

Analysis of expired medications in Serbian households
by: Paut Kusturica Milica, et al.
Published: (2016)

Are There Striking Differences in Outpatient Use of Antibiotics Between South Backa District, Serbia, and Some Scandinavian Countries?
by: Olga Horvat, et al.
Published: (2018)

Preclinical Evaluation of Nitroxide-Functionalised Ciprofloxacin as a Novel Antibiofilm Drug Hybrid for Urinary Tract Infections
by: Sophia Hawas, et al.
Published: (2023)

Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing <i>Enterobacterales</i> in Patients with Invasive Urinary Tract Infection Considering Renal Function
by: Yukihiro Hamada, et al.
Published: (2022)

Increase and Change in the Pattern of Antibiotic Use in Serbia (2010-2019)
by: Ana Tomas, et al.
Published: (2021)

Challenges of Providing Access to Cutting-Edge Cancer Medicines in the Countries of Eastern Europe
by: Zdenko Tomić, et al.
Published: (2018)

Prevalence of diabetes mellitus and antidiabetic drug utilization in the Eastern Bosnia and Herzegovina: A pilot study
by: Popržen Jelena D., et al.
Published: (2018)

ACUTE COMPLICATED URINARY TRACT INFECTIONS IN CHILDREN
by: Ana Blejc Novak, et al.
Published: (2023)

Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study
by: Hao Liang, et al.
Published: (2024)

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
by: Frost C, et al.
Published: (2018)

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects
by: Cui Y, et al.
Published: (2013)

Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose
by: Daniele Veritti, et al.
Published: (2023)

Acidic Urine pH and Clinical Outcome of Lower Urinary Tract Infection in Kidney Transplant Recipients Treated with Ciprofloxacin and Fosfomycin
by: Soraya Herrera-Espejo, et al.
Published: (2024)

Editorial: Pharmacokinetic Evaluation and Modeling of Clinically Significant Drug Metabolites
by: Constantin Mircioiu, et al.
Published: (2021)

Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin
by: Martin Šíma, et al.
Published: (2022)

Evaluation of Resistance to Ciprofloxacin and Identification of Mutations in Topoisomerase Genes in Escherichia coli and Klebsiella pneumonia Isolated from Pediatric Urinary Tract Infections
by: Keyghobad Ghadiri, et al.
Published: (2019)

Toward Model-Informed Precision Dosing for Remimazolam: A Population Pharmacokinetic-Pharmacodynamic Analysis
by: Yueting Chen, et al.
Published: (2024)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
by: Yaxin Fan, et al.
Published: (2022)

Optimizing Antimicrobial Therapy by Integrating Multi-Omics With Pharmacokinetic/Pharmacodynamic Models and Precision Dosing
by: Hui-Yin Yow, et al.
Published: (2022)

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]
by: Cui Y, et al.
Published: (2014)

Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model
by: Jurij Aguiar Zdovc, et al.
Published: (2021)

ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs
by: Tridib Chaira, et al.
Published: (2023)

Treatment of Non - Complicated Lower Urinary Tract Infection in Pregnancy: Single Dose Fosfomycin Tromethamine Versus Multiple Dose Nitrofurantoin
by: Murat Özel, et al.
Published: (2011)

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia
by: Xingchen Bian, et al.
Published: (2024)

The Pharmacokinetics and Pharmacodynamics of Iron Preparations
by: Susanna Burckhardt, et al.
Published: (2011)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022)

A semimechanistic population pharmacokinetic and pharmacodynamic model incorporating autoinduction for the dose justification of TAS‐114
by: Hikari Araki, et al.
Published: (2022)

Single and Repeated Doses of EGb 761® do not Affect Pharmacokinetics or Pharmacodynamics of Rivaroxaban in Healthy Subjects
by: Robert Hoerr, et al.
Published: (2022)

Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis
by: Junzhen Wu, et al.
Published: (2023)

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects
by: He X, et al.
Published: (2022)

Pharmacokinetics/pharmacodynamics of glucocorticoids: modeling the glucocorticoid receptor dynamics and dose/response of commonly prescribed glucocorticoids
by: David Levitt
Published: (2024)

No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses
by: Martin Šíma, et al.
Published: (2021)

The influence of detoxification agents on the intensity of side effects caused by medium-high doses of methotrexate in children with acute lymphoblastic leukemia: Case series
by: Šumar Jovana S., et al.
Published: (2014)

Clinical Management of Complicated Urinary Tract Infection
Published: (2011)

Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This Disease
by: Tanja Šarenac, et al.
Published: (2019)

Lower urinary tract symptoms are beyond lower urinary tract
by: Ming-Ping Wu
Published: (2015)

The influence of telmisartan on metformin pharmacokinetics and pharmacodynamics
by: Jiagen Wen, et al.
Published: (2019)